Lab tech checking sample on Bioreactor

Reach Our Mammalian Experts:

mammalian@lonza.com

As a leader in the development and manufacture of biopharmaceuticals, Lonza is committed to an ongoing technology development program to improve our current mammalian cell culture service for recombinant protein production.  We are very involved in on-site research programs, academic collaborations, commercial collaborations and the in licensing of novel technologies. Our collaborative partners are recognized global leaders and allow us to combine industry leading knowledge to offer you the most advanced systems.

 

The Technology Development Team

Technology development project teams encompass all the skills that are required to achieve a successful outcome for mammalian expression for therapeutic products. One of our new product groups is focused on bringing in technologies and services to add to our portfolio. The results of these efforts will culminate in state-of-the-art services that can be applied to the development of the next generation of biopharmaceuticals with improved characteristics for both therapeutic efficacy and manufacturability.

Some of Our Current Projects Include:

  • New CHOK1SV GS Knock Out Expression System
  • Optimization of bioreactor processes for productivity and product quality 
  • Development of high yielding cell lines that will allow Lonza to remain at the leading edge in commercial manufacture of recombinant proteins 
  • High throughput screening for improved selection of highly productive cell lines 
  • Engineered cell lines to enhance desirable product characteristics 
  • Development of protein engineering platforms to increase product manufacturability

 

New developments are tested extensively in-house before being offered to customers. Constant monitoring of performance ensures that our technology meets the high standards that we demand and you expect.

Return to other Process R&D Services